Completed PHASE4 INTERVENTIONAL 2-arm NCT03044080

Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot

Effects of Repeated Use of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot in Stroke Patients: A Randomized Clinical Trial

Sponsor: Parc de Salut Mar

Conditions Stroke Rehabilitation Stroke Rehabilitation Spasticity Management

Interventions IncobotulinumtoxinA OnabotulinumtoxinA

Updated 6 times since 2017 Last updated: Oct 19, 2017 Started: Jan 1, 2015 Primary completion: Jun 30, 2017 Completion: Sep 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Stroke Rehabilitation and Stroke Rehabilitation Spasticity Management, this trial is completed. The trial is conducted by Parc de Salut Mar and has accumulated 6 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Nov 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 1 earlier version

Feb 2017 — Nov 2017 [monthly]

Recruiting PHASE4

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Parc de Salut Mar

Data source: Parc de Salut Mar

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain